U.S. Polyglycolic Acid Market Size, Share & Forecast 2026–2032

ID: MR-11666 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Polyglycolic Acid Market
  • ✓Market Size 2024: USD 48.5 million
  • ✓Market Size 2032: USD 102.5 million
  • ✓CAGR: 9.8%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
Oilfield Demand Reshaping Volumes: Dissolvable downhole plugs for Permian Basin fracturing are steadily gaining volume on U.S. PGA demand, challenging the medical suture segment's historical dominance. Kureha Corporation's Japanese supply sets the pricing floor for American converters, exposing buyers to yen swings.
FINDING 02
Sutures Resist Substitution: The assumption that bio-based PLA will displace PGA in U.S. absorbable sutures is overstated. Surgeons need the predictable, faster strength loss of glycolide polymers, which keeps Ethicon and Medtronic formulations entrenched in hospital contracts through 2032.
ANALYST RECOMMENDATION

Analyst Recommendation — Secure Compounding and Supply: Buyers should qualify a second PGA compounding source and lock Kureha supply terms by Q4 2026, since yen volatility and Section 301 tariffs on Chinese intermediates threaten margins. Investors should prioritise Texas compounding sites serving Permian completions.

U.S. Polyglycolic Acid: Market Overview

The U.S. polyglycolic acid market is small in tonnage but commercially concentrated, reflecting a supply base that is almost entirely imported. Domestic demand is anchored in absorbable surgical sutures regulated by the FDA under 21 CFR 878.4840, and in dissolvable downhole tools used in shale completions. Japan's Kureha Corporation supplies most of the resin consumed by American compounders, giving the country a structure distinct from the global market, where Chinese capacity is expanding rapidly.

The estimated 2024 market value of USD 48.5 million reflects premium pricing rather than volume leadership. American spend per kilogram runs well above Asian packaging-film pricing because medical-grade and downhole-certified resins carry compliance costs. Participants therefore compete on regulatory documentation and supply continuity rather than on unit cost alone.

Growth Drivers for Polyglycolic Acid in the U.S.

Shale completion activity is the most distinctive driver. Dissolvable frac plugs made from PGA eliminate milling steps in Permian Basin and Eagle Ford horizontal wells, cutting rig time and operator costs. Operators such as ExxonMobil and Chevron, both active in Permian development, continue to expand multistage fracturing programmes that raise plug consumption per well.

Medical demand is driven by an ageing population and rising procedure volumes tracked by the Centers for Medicare and Medicaid Services. Outpatient surgery reimbursement under the CMS Outpatient Prospective Payment System favours absorbable sutures that avoid removal visits. Packaging demand for barrier films, governed by FDA food contact notifications, adds a smaller third stream.

Market Restraints and Entry Barriers

Regulatory timelines are the principal barrier. Absorbable sutures require FDA 510(k) clearance, which typically takes six to twelve months, and any change in polymer grade or sterilisation method can trigger a new submission. New entrants must also comply with the Quality Management System Regulation, which aligns with ISO 13485 from February 2026.

Supply concentration and tariff exposure restrain margins. Kureha's Japanese production leaves U.S. compounders dependent on transpacific freight and yen-denominated pricing. Section 301 duties on Chinese-origin intermediates raise landed costs for lower-grade converters, while PLA and PDO substitutes compress prices in suture applications.

Market Opportunities in the U.S. Polyglycolic Acid Sector

Domestic compounding for Permian operators is the nearest opportunity. Oilfield service firms want local supply to shorten lead times on dissolvable plugs, and a Texas compounding plant could address an estimated USD 12 million of annual downhole resin demand. Early qualification with completion-tool manufacturers allows suppliers to lock multi-year volumes before 2028.

Contract compounding for absorbable implants offers a second route. Orthopaedic and cardiovascular device makers in the Midwest increasingly outsource resin preparation, creating an addressable pool estimated at USD 9 million. Suppliers holding ISO 13485 certification and FDA Drug Master File access can capture share from offshore compounders.

Market at a Glance

MetricU.S. Polyglycolic Acid Market
Market Size 2024USD 48.5 million
Market Size 2032USD 102.5 million
Growth Rate (CAGR)9.8%
Most Critical Decision FactorSecured Kureha supply and FDA-compliant documentation
Largest RegionSouth (Texas and Gulf Coast)
Competitive StructureConcentrated; Kureha-led resin supply with few medical converters

Leading Market Participants

  • Kureha Corporation
  • Johnson & Johnson (Ethicon)
  • Medtronic
  • Smith & Nephew
  • B. Braun Melsungen
  • Teleflex
  • Halliburton
  • Baker Hughes
  • Corbion
  • Evonik Industries

Regulatory and Policy Environment for Polyglycolic Acid in the U.S.

The FDA regulates finished absorbable sutures as Class II devices requiring 510(k) premarket notification, while resin used in food-contact films requires a Food Contact Notification under FFDCA Section 409. The Toxic Substances Control Act governs PGA as a chemical substance, requiring TSCA inventory compliance and Section 5 notices for new uses. The U.S. Pharmacopeia monograph for absorbable surgical sutures sets purity thresholds that compounders must verify.

Trade policy shapes sourcing. Section 301 tariffs apply to many Chinese-origin chemical intermediates, and importers must verify HTS classification with U.S. Customs and Border Protection. Quality Management System Regulation compliance takes effect in February 2026, requiring documented design controls and supplier audits within twelve to eighteen months. No federal subsidy targets PGA directly, so Texas Chapter 403 JETI agreements are the realistic incentive route for new compounding capacity.

Long-Term Outlook for the U.S. Polyglycolic Acid Market

By 2032 the U.S. market is projected to reach USD 102.5 million, growing at a CAGR of 9.8% from the 2025 base year. Growth will concentrate in downhole applications, where Permian completion intensity keeps dissolvable plug consumption rising. Medical demand will grow more steadily, anchored by suture reimbursement and surgical volume.

The competitive structure will remain concentrated around Kureha's supply and a small group of medical converters. Entrants that secure domestic compounding and FDA-ready documentation by 2028 will gain qualification advantages that offshore suppliers cannot match. Pricing power will favour suppliers that reduce yen and tariff exposure.

Frequently Asked Questions

Qualifying a Texas-based compounding partner that serves Permian plug manufacturers is the fastest route. It avoids FDA device clearance because the supplier sells resin rather than finished devices.
Resin suppliers do not need device clearance themselves, but they must supply material documentation that supports the 510(k) submissions of their customers. Suppliers should also maintain ISO 13485 aligned quality systems.
Section 301 duties apply to many Chinese-origin chemical intermediates, alongside standard most-favoured-nation duties. Importers should confirm HTS classification with U.S. Customs and Border Protection before contracting.
Texas Chapter 403 JETI agreements provide school property tax limitations for qualifying manufacturing investments. Projects must demonstrate job creation and capital investment thresholds set by the state.
Concentrated dependence on Kureha Corporation's Japanese production exposes buyers to yen volatility and transpacific freight disruption. Securing a second compounding source and multi-year supply terms reduces this exposure.

Market Segmentation

By Application
  • Absorbable Surgical Sutures
  • Dissolvable Downhole Plugs
  • Absorbable Implants
  • Barrier Packaging Films
  • Others
By End User
  • Medical Device Manufacturers
  • Oilfield Service Companies
  • Hospitals and Surgical Centers
  • Packaging Converters
  • Others
By Product Form
  • Medical-Grade Resin
  • Downhole-Grade Resin
  • Monofilament Fibers
  • Barrier Films

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 U.S. Polyglycolic Acid Market - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Application Insights
4.1 Absorbable Surgical Sutures
4.2 Dissolvable Downhole Plugs
4.3 Absorbable Implants
4.4 Barrier Packaging Films
4.5 Others
Chapter 05 End User Insights
5.1 Medical Device Manufacturers
5.2 Oilfield Service Companies
5.3 Hospitals and Surgical Centers
5.4 Packaging Converters
5.5 Others
Chapter 06 Product Form Insights
6.1 Medical-Grade Resin
6.2 Downhole-Grade Resin
6.3 Monofilament Fibers
6.4 Barrier Films
6.5 Others
Chapter 07 Competitive Landscape
7.1 Market Players
7.2 Leading Market Participants
7.2.1 Kureha Corporation
7.2.2 Johnson & Johnson (Ethicon)
7.2.3 Medtronic
7.2.4 Smith & Nephew
7.2.5 B. Braun Melsungen
7.2.6 Teleflex
7.2.7 Halliburton
7.2.8 Baker Hughes
7.2.9 Corbion
7.2.10 Evonik Industries
7.3 Regulatory Environment
7.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.